Publication | Closed Access
The Natural Anticancer Compounds Rocaglamides Inhibit the Raf-MEK-ERK Pathway by Targeting Prohibitin 1 and 2
158
Citations
37
References
2012
Year
Medicinal ChemistryRaf-mek-erk PathwayChemoprevention StrategyBiochemistryMedicineNatural SciencesReceptor Tyrosine KinaseMechanism Of ActionAnti-cancer AgentProhibitin 1PharmacologyCancer ResearchInhibitory ActivityTumor BiologyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1